MetLife Financial Statements
NYSE: METFinanceLife InsuranceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MetLife revenue and earnings
In fiscal 2025, MetLife generated $77.08 billion in revenue, up 8.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $3.38 billion (-23.7% year over year), for a net margin of 4.4% versus a median of 7.7% in the prior 5 years. Operating margin was 8.0%.
Diluted earnings per share came in at $4.71, down from $5.94. Over the last 5 fiscal years, MET's revenue has grown at a 2.6% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
MetLife income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.08B | 70.99B | 66.91B | 68.77B | 68.70B | 67.84B | 69.62B | 67.94B | 62.31B | 60.79B |
| Revenue growth (YoY) | +8.59% | +6.10% | -2.71% | +0.11% | +1.26% | -2.55% | +2.47% | +9.04% | +2.50% | -0.91% |
| Operating Expenses | 13.86B | 13.02B | 12.71B | 11.86B | 12.02B | 13.15B | 13.69B | 13.71B | 13.62B | 13.75B |
| Selling, General & Admin | 7.35B | 6.50B | 6.65B | 5.93B | 6.13B | 6.36B | 6.90B | 6.62B | 6.52B | 6.75B |
| Operating Income | 6.14B | 6.00B | 5.72B | 5.98B | — | — | — | — | — | — |
| Interest Expense | 724.00M | 738.00M | 740.00M | 655.00M | 647.00M | 632.00M | 656.00M | 827.00M | 841.00M | 874.00M |
| Pretax Income | 4.66B | 5.62B | 2.16B | 6.36B | 8.52B | 6.93B | 6.79B | 6.31B | 3.54B | 4.28B |
| Income Tax | 1.26B | 1.18B | 560.00M | 1.06B | 1.64B | 1.51B | 886.00M | 1.18B | -1.47B | 693.00M |
| Net Income | 3.38B | 4.43B | 1.58B | 5.28B | 6.86B | 5.41B | 5.90B | 5.12B | 4.01B | 850.00M |
| Net Income growth (YoY) | -23.66% | +180.48% | -70.14% | -22.92% | +26.78% | -8.34% | +15.15% | +27.76% | +371.76% | -84.18% |
| EPS (Basic) | 4.74 | 5.98 | 1.82 | 6.35 | 7.71 | 5.72 | 6.10 | 4.95 | 3.65 | 0.68 |
| EPS (Diluted) | 4.71 | 5.94 | 1.81 | 6.30 | 7.65 | 5.68 | 6.06 | 4.91 | 3.62 | 0.67 |
| Shares Outstanding (Basic) | 668.90M | 706.40M | 757.70M | 803.20M | 862.70M | 907.80M | 937.60M | 1.01B | 1.07B | 1.10B |
| Shares Outstanding (Diluted) | 673.30M | 711.10M | 762.30M | 808.90M | 869.40M | 913.20M | 944.40M | 1.01B | 1.08B | 1.11B |
| EBITDA | 6.25B | 6.12B | 5.83B | 6.10B | — | — | — | — | — | — |
| Operating Margin | 7.96% | 8.45% | 8.55% | 8.69% | — | — | — | — | — | — |
| Net Margin | 4.38% | 6.24% | 2.36% | 7.68% | 9.98% | 7.97% | 8.47% | 7.54% | 6.44% | 140.00% |
This table shows 10 annual periods of MetLife's income statement, from FY 2025 back to FY 2016, across 15 line items including revenue, operating expenses, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow MET's reporting calendar. What is a income statement?